141 related articles for article (PubMed ID: 21332316)
1. Transcriptional profiling to identify biomarkers of disease and drug response.
Mendrick DL
Pharmacogenomics; 2011 Feb; 12(2):235-49. PubMed ID: 21332316
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as potential biomarkers in diseases and toxicology.
Siddeek B; Inoubli L; Lakhdari N; Rachel PB; Fussell KC; Schneider S; Mauduit C; Benahmed M
Mutat Res Genet Toxicol Environ Mutagen; 2014 Apr; 764-765():46-57. PubMed ID: 24486656
[TBL] [Abstract][Full Text] [Related]
3. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
Herder C; Karakas M; Koenig W
Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as potential biomarkers of smoking-related diseases.
Banerjee A; Luettich K
Biomark Med; 2012 Oct; 6(5):671-84. PubMed ID: 23075247
[TBL] [Abstract][Full Text] [Related]
6. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
Fichtlscherer S; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
[TBL] [Abstract][Full Text] [Related]
8. Genomic and genetic biomarkers of toxicity.
Mendrick DL
Toxicology; 2008 Mar; 245(3):175-81. PubMed ID: 18206287
[TBL] [Abstract][Full Text] [Related]
9. Identification of drug-induced toxicity biomarkers for treatment determination.
Lu TP; Chen JJ
Pharm Stat; 2015; 14(4):284-93. PubMed ID: 25914330
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
11. Novel biomarkers of acute kidney toxicity.
Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
[TBL] [Abstract][Full Text] [Related]
12. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
13. The role for microRNAs in drug toxicity and in safety assessment.
Marrone AK; Beland FA; Pogribny IP
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):601-11. PubMed ID: 25739314
[TBL] [Abstract][Full Text] [Related]
14. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
15. microRNAs as mediators of drug toxicity.
Yokoi T; Nakajima M
Annu Rev Pharmacol Toxicol; 2013; 53():377-400. PubMed ID: 23189953
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.
Sandhu H; Maddock H
Clin Sci (Lond); 2014 Mar; 126(6):377-400. PubMed ID: 24274966
[TBL] [Abstract][Full Text] [Related]
17. Discovery and development of biomarkers of neurological disease.
Dunckley T; Coon KD; Stephan DA
Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
[TBL] [Abstract][Full Text] [Related]
18. Diabetes in post genomic era: promises to discover biomarkers and new drug targets.
Ahmed M
Mymensingh Med J; 2008 Jul; 17(2 Suppl):S111-5. PubMed ID: 18946443
[TBL] [Abstract][Full Text] [Related]
19. An approach to identifying preclinical biomarkers of susceptibility to drug-induced toxicity.
Lin WJ; Chen JJ
Pharmacogenomics; 2011 Apr; 12(4):493-501. PubMed ID: 21521022
[TBL] [Abstract][Full Text] [Related]
20. Translation of neurological biomarkers to clinically relevant platforms.
Hayes RL; Robinson G; Muller U; Wang KK
Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
